Stamford, CT -- (SBWIRE) -- 12/13/2013 -- High Rising Stocks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: EMC Corporation(NYSE:EMC), Synta Pharmaceuticals Corp.(NASDAQ:SNTA), Sequenom, Inc.(NASDAQ:SQNM), Provectus Pharmaceuticals, Inc.(OTCMKTS:PVCT)
EMC Corporation(NYSE:EMC) opened the session at $23.25, remained amid the day range of $23.15 - $23.35, and closed the session at $23.15. The stock showed a negative performance of -0.77% in previous trading session. The stock gained a volume of 23.39 million shares and the average volume of the stock remained 19.71 million shares. EMC Corporation, together with its subsidiaries, develops, delivers, and supports information infrastructure and virtual infrastructure technologies, solutions, and services.
Will EMC Get Buyers Even After The Recent Rally? Find Out Here
Synta Pharmaceuticals Corp.(NASDAQ:SNTA) traded with volume of 5.97 million shares in the prior session and the average volume of the stock remained 2.09 million shares. The 52 week range of the stock remained $3.70 - $11.88. The stock showed a positive movement of +3.01% and closed its session at $4.79. The market capitalization of the stock remained 408.12 million. Synta Pharmaceuticals Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs for treating severe medical conditions, including cancer and chronic inflammatory diseases.
Will SNTA Continue To Move Higher? Find Out Here
Sequenom, Inc.(NASDAQ:SQNM) exchanged 3.27 million shares and the average volume remained 3.03 million shares. The stock dropped -4.49% and closed the session at $2.02. The beta of the stock remained 0.40 and the EPS of the stock remained -1.05. The shares outstanding of the stock remained 115.72 million. Sequenom, Inc., a life sciences company, provides genetic analysis solutions in the United States and internationally. It operates through two segments, Molecular Diagnostics and Genetic Analysis.
Has SQNM Found The Bottom And Ready To Gain Momentum? Find Out Here
Provectus Pharmaceuticals, Inc.(OTCMKTS:PVCT) gained volume of 2.10 million shares, while the average volume remained 564,332.00 shares. The stock advanced +16.22% and finished the session Thursday at $1.29. The EPS of the stock remained -0.10. The one month of the stock was 93.94%. Provectus Pharmaceuticals, Inc., a development-stage pharmaceutical company, engages in developing pharmaceuticals for oncology and dermatology indications.
For How Long PVCT’s Gloss will Attract Investors ? Find out via this report
High Rising Stocks provides investors with the hottest penny stock alerts on a regular basis. It carries Hot Penny Stocks and Penny Stock Newsletter, we will send you alerts through our Free Penny Stock Newsletters with High Yielding alerts, market forecasting, stock tips and strategies, and offer you the tools to help you along the way with the goal of keeping you loyal to our service.
Carriage Consulting Group, High Rising Stocks, their Members, officers, directors, employees, affiliates, or any other related person(s) (collectively, “High Rising Stocks”) are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. High Rising Stocks as defined are neither licensed nor qualified to provide investment advice and you are specifically and adamantly advised not to rely upon anything said/posted/communicated/implied or expressed by High Rising Stocks as defined.
Read full Disclaimer at: http://highrisingstocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)